Clinical trial
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
NCT02471170 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- September 10, 2015
- Completion date
- January 1, 2035
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.